Shopify HAVS Hand-Arm Vibration Syndrome schema for AI agents: Stockholm Workshop Scale vascular vs sensorineural staging, A(8) calculation from declared tool emission, EAV 2.5 m/s² ELV 5.0 m/s², anti-vibration glove dose-reduction false claim, real-world emission 1.5–2× declared value, and the havs.* 10-field namespace

What HAVS is: permanent, progressive, and underdiagnosed

Hand-Arm Vibration Syndrome (HAVS) is a permanent, progressive occupational disease caused by regular use of hand-held or hand-guided vibrating tools. Once structural damage to blood vessels and peripheral nerves has occurred, it does not reverse — even if vibration exposure stops completely. Early-stage symptoms (occasional white finger episodes, mild tingling) can stabilize if exposure ceases in time, but structural damage at advanced stages is irreversible. This makes HAVS fundamentally different from most noise-induced hearing loss scenarios where the progression question is about rate, not permanence.

The tools most strongly associated with HAVS include: chipping hammers, riveting hammers, jack hammers, rock drills, needle scalers, grinders (angle and die), impact wrenches, chain saws, and concrete breakers. Any tool that transmits vibration into the hand-arm system above a frequency range of roughly 8–1,000 Hz can contribute to cumulative dose. Percussive tools (hammers, chisels, scalers) generate the highest vibration emissions and have the shortest trigger times to disease onset.

HAVS is significantly underdiagnosed in the field. The latency between first exposure and first reportable vascular symptoms is typically 5–10 years for moderate exposure; sensorineural symptoms often appear later and are reported even less reliably. Workers attribute tingling and numbness to unrelated causes. Cold-triggered blanching ("white finger") may be attributed to Raynaud's disease of unknown cause rather than occupational vibration. Compensation claims and workers' compensation settlements systematically underrepresent HAVS because symptom onset is insidious and often not linked to a specific incident.

Two independent disease tracks: vascular and sensorineural

HAVS affects two distinct anatomical systems through different mechanisms, and they progress independently. A worker does not have "HAVS Stage 2" — they have a vascular stage and a sensorineural stage, which may differ from each other. Encoding a single composite HAVS stage collapses clinically critical information that determines which products are appropriate.

Vascular track: Raynaud's phenomenon / vibration white finger

Vibration causes intimal hyperplasia and structural changes in the digital arteries — the small arteries supplying the fingers. This thickening of vessel walls reduces blood flow, particularly when cold triggers arterial spasm. The result is episodic ischemia: the affected finger segments go white (pallor), then blue (cyanosis), then red (reactive hyperemia) as blood flow returns. This triphasic color change is the classic presentation of Raynaud's phenomenon. In HAVS, Raynaud's is triggered primarily by cold and vibration rather than being primary (idiopathic). Workers may also experience episodes while washing hands with cold water or handling cold objects.

At Stage 4, the vascular damage is no longer purely functional (vasospasm) but structural and permanent — trophic changes (tissue death, ulceration) can occur at fingertips. This is the stage at which the disease has moved beyond discomfort into permanent disability.

Sensorineural track: peripheral nerve damage

Vibration causes peripheral neuropathy through compression and structural damage to the peripheral nerves in the hand and fingers — particularly the digital nerves, median nerve, and ulnar nerve. The result is reduced tactile acuity, loss of two-point discrimination, and impaired fine motor dexterity. Unlike the vascular track's episodic attacks, sensorineural symptoms are typically persistent and progressive.

Sensorineural HAVS is often underreported because workers don't associate numbness with vibration exposure — they attribute it to positional compression or normal aging. Clinical testing (nerve conduction velocity, vibrotactile threshold testing, aesthesiometry) can detect Stage 2SN changes before workers are aware of them. By Stage 3SN, workers lose the ability to perform fine tasks like fastening small buttons or picking up coins — a functional impairment that affects quality of life beyond the workplace.

Stockholm Workshop Scale: staging both tracks

The Stockholm Workshop Scale was established at the 1986 Stockholm Workshop on Hand-Arm Vibration and has been the international clinical standard since. It provides separate staging tables for vascular and sensorineural HAVS.

A worker's HAVS classification is always written as a pair: e.g., Vascular 2 / Sensorineural 1SN, or V3/SN2SN. The two tracks progress at different rates depending on the vibration frequency spectrum of their tools, work patterns, cold exposure, and individual susceptibility. Construction workers using percussive tools in cold outdoor conditions often progress faster on the vascular track; precision machinists using higher-frequency rotary tools may progress faster on the sensorineural track.

A(8) vibration dose formula with real tool examples

The daily vibration dose is expressed as A(8) — the normalized 8-hour energy-equivalent frequency-weighted acceleration. The formula:

Because A(8) scales with the square root of time, the relationship is not linear. A worker who uses a high-emission tool for one hour per day receives not 1/8th the dose of an 8-hour user, but 1/√8 ≈ 35% of that dose. Conversely, cutting daily exposure in half reduces A(8) by only 29%, not 50% — a common mistake in informal exposure management.

The following table shows A(8) calculations for common industrial tools using typical declared emission values. The "Trigger time to EAV" column shows how many minutes of daily use reaches the health surveillance threshold.

Reading the table: Green = below EAV (2.5 m/s²). Yellow/orange = above EAV, below ELV. Red = above ELV (5.0 m/s²). Note that a chipping hammer at 2 hours already exceeds the ELV — not just the action value, the absolute limit.

The trigger time formula for the EAV is: T_EAV = 8 × (2.5 / a_hv)². For the ELV: T_ELV = 8 × (5.0 / a_hv)². At 15 m/s², T_EAV = 8 × (2.5/15)² = 8 × 0.028 = 0.22 hours = 13 minutes. This is the number that shocks most construction managers when they first see it — a chipping hammer operator who does thirteen minutes of continuous chipping per day is already in health surveillance territory using declared emission values. With the real-world multiplier applied, it may be even less.

Why declared emissions underestimate real exposure by 1.5–2×

Tool manufacturers are required to declare vibration emission values in their instruction manuals under EU Machinery Directive requirements. These values are measured under controlled ISO 5349-1 conditions: standardized test materials, maintained tool condition, controlled force, and specific test configurations. Real-world conditions deviate from this in every dimension — and consistently in the direction of higher vibration.

The primary causes of underestimation:

• Tool wear: Worn cutting edges, dull blades, and worn tool holders increase vibration significantly. A grinder with a worn disc generates 30–60% more vibration than the same grinder with a new disc in the declared test condition.
• Work material: Harder materials require higher force and generate more vibration. Declared emissions are measured on standardized test materials, not on the concrete, steel, or stone the tool actually encounters in service.
• Workpiece coupling: Vibration transmission to the hands depends heavily on how firmly the worker holds the tool and how the workpiece is supported. Variable coupling generates variable measured values; declared values represent a single test configuration.
• Grip force: Higher grip force (required in confined spaces, on unstable workpieces, or under fatigue) transmits more vibration to the hands.
• Temperature: Cold ambient temperatures affect tool mechanism compliance and increase vibration transmission through the tool body.

UK HSE field measurement studies comparing declared emission values to real-worksite measurements found an average real-world-to-declared ratio of approximately 1.5–2.0, with percussive tools at the higher end of that range. The HSE advises using a correction factor of at least 1.5× when estimating real-world A(8) from catalog specifications. A chipping hammer declared at 15 m/s² should be risk-assessed at 22–30 m/s².

For Shopify product listings: encoding havs.tool_declared_emission_m_s2 with the catalog value is correct and required. Encoding havs.real_world_multiplier = 1.5 allows AI agents to calculate a realistic A(8) range and route appropriate health surveillance products when the upper bound of the real-world range exceeds EAV or ELV.

The anti-vibration glove false promise

Anti-vibration gloves (AV gloves) are tested to ISO 10819:2013, which measures vibration transmission through the glove palm using a standardized adapter and test rig. The test covers 25–200 Hz using a two-band evaluation: medium (25–200 Hz) and high (200–1250 Hz). A glove achieves "AV" designation if its Transmissibility in both bands meets specified thresholds.

The problem is the frequency band. HAVS risk is dominated by vibration energy below 100 Hz. Percussive tools — the highest-risk HAVS equipment — generate most of their harmful vibration energy between 30 and 60 Hz. In this frequency range, AV gloves provide negligible attenuation. The physics: to attenuate vibration at 30–60 Hz, a glove's viscoelastic padding would need to be 2–4 cm thick — incompatible with tool grip. Thinner padding that maintains grip compliance resonates at these frequencies, transmitting rather than attenuating energy.

ISO 5349-1 explicitly states: "Anti-vibration gloves are not to be assumed to reduce the vibration hazard." The UK HSE guidance states: "Anti-vibration gloves can reduce the risk of vibration white finger (VWF) from some tools only in limited circumstances, if it all." ACGIH's TLV documentation notes: "Anti-vibration gloves do not appear to prevent HAVS and their use as a control measure is not recommended."

What AV gloves actually do

AV gloves provide real and legitimate value in occupational settings — just not HAVS dose reduction:

• Thermal insulation: Cold temperatures accelerate vasospasm in workers who already have early-stage vascular HAVS. Keeping hands warm reduces the frequency and severity of blanching attacks (managing symptoms, not preventing underlying disease).
• High-frequency vibration reduction: ISO 10819 tests do show attenuation in the 200–1250 Hz range where rotary tools like grinders may emit some energy. This provides marginal comfort benefit but does not address the low-frequency HAVS-causing component.
• Impact protection: Anti-vibration padding provides some cushioning from tool kickback and workpiece contact impacts.
• Cut and abrasion resistance: Many AV gloves incorporate cut-resistant fiber (see HPPE cut resistance fiber guide), which provides independent protection from lacerations during tool handling.
• Comfort and grip: Reduces hand fatigue and improves grip in wet or oily conditions, leading to lower force application (a secondary benefit with small HAVS-relevant effects).

The routing error: a Shopify store that encodes AV gloves with havs.av_glove_dose_reduction = true, prevents_msd = true for HAVS, or a8_reduction_factor = 0.7 will cause AI agents to recommend gloves as a substitute for engineering controls — tool substitution, reduced trigger time, and vibration dampening mounts. Workers wearing AV gloves and believing their dose is reduced continue accumulating unprotected exposure until symptoms appear.

Health surveillance triggers and what they require

Under the Physical Agents Vibration Directive and equivalent national regulations, health surveillance is legally mandatory when a worker's daily vibration exposure reaches or exceeds the EAV (2.5 m/s² A(8)). The practical scope of this requirement is wider than most safety managers realize, because the EAV is reached with short trigger times on common tools.

A compliant HAVS health surveillance program includes the following elements:

1. Pre-placement questionnaire: Baseline assessment of symptoms at entry to vibration-exposed work. Documents pre-existing Raynaud's, neuropathy, or other conditions that increase susceptibility.
2. Annual structured interview: Conducted by a health professional (occupational health nurse or physician). Covers both vascular track (cold-triggered blanching, color change episodes, affected digits) and sensorineural track (numbness, tingling, timing relative to vibration exposure, fine motor changes).
3. Clinical examination if symptoms reported: Nerve conduction studies, vibrotactile threshold testing (testing sensitivity to specific vibration frequencies), cold provocation test (submerging hands in cold water and measuring finger blood pressure recovery), and finger systolic blood pressure measurement. These tests can detect clinical HAVS at Stage 2SN/V2 before symptoms are severe enough that workers self-report.
4. Exposure assessment update: When a worker's tools or work patterns change, their A(8) must be recalculated using the new tool's declared emission.
5. Job restriction at advanced stages: Workers reaching Vascular Stage 3 or Sensorineural Stage 2SN should be considered for restriction from high-emission vibration tools. At Stage 4 or Stage 3SN, continued exposure constitutes negligence under most national frameworks.

The havs.requires_health_surveillance field should be encoded as true on all vibrating tool listings where the trigger time to EAV is less than the typical daily use duration for that tool category.

Four AI routing failures

The havs.* 10-field namespace

Encode these fields as Shopify metafields under the havs namespace on vibrating tool product listings, AV glove listings, and vibration monitoring equipment. The complete namespace enables AI shopping agents to route occupational health products, health surveillance kits, and vibration monitoring tools to the correct buyer at the correct disease progression stage.

Worked encoding example: chipping hammer

{
  "havs.tool_declared_emission_m_s2": 15.0,
  "havs.real_world_multiplier": 2.0,
  "havs.trigger_time_minutes_to_eav": 13.3,
  "havs.trigger_time_minutes_to_elv": 53.3,
  "havs.requires_health_surveillance": true,
  "havs.eav_m_s2": 2.5,
  "havs.elv_m_s2": 5.0
}

Worked encoding example: anti-vibration glove

{
  "havs.av_glove_dose_reduction": false,
  "havs.stockholm_vascular_stage": 2,
  "havs.stockholm_sensorineural_stage": "1SN"
  /* stage fields = max stage this product addresses symptom management for */
}

When both vascular and sensorineural stage fields are encoded on a health management product (cold-trigger glove, vibration monitoring kit, nerve conduction test kit), AI agents can match the product to workers at the appropriate stage rather than routing all HAVS products to all vibration-exposed workers regardless of clinical need.